[1] Adali , M.,İnal-Erden,Akalin , A.,Efe , B.N., 1999.Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients,Clin. Biochem 9120 00024 -7
[2] Ahmed , S.N.,Siddiqi , Z.A., 2005.Antiepileptic drugs and liver disease,Seizure 12 156 -164
[3] Bosch , J.,Masti , R.,Kravetz , D.,Bruix , J.,Gaya , J.,Rigau , J.,Rodes , J., 1984.Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis,Hepatology 4 1200 -1205
[4] Cengiz , M.,Ali , J.H.,Kutlu , M,,Vejselova , D.,Ayhanci , A., 2017.Potential recruiting and hepatoprotective effects of ellagic acid in D-galactosamine-induced liver damage in rats,Pakistan J. Zool. 49 1251 -1259
[5] Chalasani , N.,Bjornsson , E., 2010.Risk factors for idiosyncratic drug-induced liver injury,Gastroenterology 04 2246 -2259
[6] Chalasani , N.,Bonkovsky , H.L.,Fontana , R.,Lee , W.,Stolz , A.,Talwalkar , J.,Reddy , K.R.,Watkins , P.B.,Navarro , V.,Barnhart , H.,Gu , J.,Serrano , J., 2015.Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study,Gastroenterology 03 1340 -1352
[7] Chalasani , N.,Fontana , R.J.,Bonkovsky , H.L.,Watkins , P.B.,Davern , T.,Serrano , J.,Yang , H.,Rochon , J., 2008.Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States, 09 1924 -1934
[8] Chen , M.,Suzuki , A.,Borlak , J.,Andrade , R.J.,Lucena , M.I., 2015.Drug-induced liver injury: Interactions between drug properties and host factors,J. Hepatol. 04 503 -514
[9] Echlin , P., 2011.Handbook of sample preparation for scanning electron microscopy and X-ray microanalysis, -
[10] Eghbal , M.A.,Taziki , S.,Sattari , M.R., 2013.Protective role of melatonin and taurine against carbamazepine-induced toxicity in freshly isolated rat hepatocytes,Int. J. Morphol. 1 1081 -1089
[11] Elliott , E.C.,Regan , S.L.,Maggs , J.L.,Bowkett , E.R.,Parry , L.J.,Williams , D.P.,Park , B.K.,Stachulski , A.V., 2012.Haloarene derivatives of carbamazepine with reduced bioactivation liabilities: 2-monohalo and 2,8-dihalo derivatives,J. med. Chem 55 9773 -9784
[12] George , M.,Joseph , L., 2016.A review article on assessing the effect of antiepileptics and statins on liver enzymes in epileptic patients,Pharma Innov. J. 5 11 -14
[13] Higuchi , S.,Yano , A.,Takai , S.,Tsuneyama , K.,Fukami , T.,Nakajima , M.,Yokoi , T., 2012.Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury,Toxicol. Sci. 130 4 -16
[14] Huang , Y.T., Cheng, Y.R.,Lin , H.C.,Hou , M.C.,Lee , S.D.,Hong, 1998.Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats,Digest. Dis. Sci. 43 358 -364
[15] Kim , C.H.,Younossi , Z.M., 2008.Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome,Cleveland Clin. J. Med 75 721 -728
[16] Lee , J.Y.,Huo , T.I.,Huang , H.C.,Lee , F.Y.,Lin , H.C.,Chuang , C.L.,Chang , C.C.,Wang , S.S.,Lee , S.D., 2011.Propranolol modulates the collateral vascular responsiveness to vasopressin via a Gα- mediated pathway in portal hypertensive rats,Clin. Sci. 121 545 -554
[17] Maheswari , E.,Saraswathy , G.R.,T., 2014.Hepatoprotective and antioxidant activity of N-acetyl cysteine in carbamazepine-administered rats,Indian J. Pharmacol. 46 129321 -7613
[18] Maheswari , E.,Saraswathy , G.R.,Raja , G.,Santhranii , T., 2015a.Effectiveness of alpha lipoic acid as hepatoprotective and antioxidant,Int. J. Pharmaceut. Chem. biol. Sci. 5 242 -248
[19] Maheswari , E.,Saraswathy , G.,Santhranii , T., 2015b.Influence of vitamin E on hepatotoxicity and oxidative stress,Int. J. Res. Pharm. Biosci. 2 30 -38
[20] Mak , I.T.,Weglicki, 2004.Potent antioxidant properties of 4-hydroxyl-propranolol,J. Pharmacol. exp. Therap. 308 85 -90
[21] Mesdjian , E.,Zamora , A.J.,Montet , A.M.,Bonneton , J.,Guitaoui , M.,Genton , P.,Montet , J. C., 1996.Ursodeoxycholate improves hepatobiliary dysfunction induced by valproate-carbamazepine treatment in the rat,Life Sci 59 00422 -5
[22] Ohnishi , K.,Nakayama , T.,Saito , M.,Hatano , H.,Tsukamoto , T.,Terabayashi , H.,Sugita , S.,Wada , K.,Nomura , F.,Koen , H.,Okuda , K., 1985.Effects of propranolol on portal hemodynamics in patients with chronic liver disease,Am. J. Gastroenterol. 80 132 -135
[23] Pandit , A.,Sachdeva , T.,Bafna , P., 2012.Druginduced hepatotoxicity: A review,J. appl. Pharmaceut. Sci. 2 233 -243
[24] Parasuraman , S.,Raveendran , R.,Kesavan , R., 2010.Blood sample collection in small laboratory animals,J. Pharmacol. Pharmacother. 1 72350 -500X
[25] Pérez-Paramo , M.,Munoz , J.,Albillos , A.,Freile , I.,Portero , F.,Santos , M.,Ortiz-Berrocal , J., 2000.Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites,Hepatology 31 43 -48
[26] Piao , M.,Liu , Y.,Yu , T.,Lu , Y., 2016.Zinc supplementation ameliorates ER stress and autophagy in liver in a rat model of type 2 diabetes mellitus,Biomed. Res. 27 970 -938
[27] Pizcueta , M.P.,de Lacy , A.M.,Kravetz , D.,Bosch , J.,Rodés , J., 1989.Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats,Hepatology 10 953 -957
[28] Prkacin , I.,Separovic , J.,Aralicia , G.,Perovic , D.,Gjurasin , M.,Lovric-Bencic , M.,Stancic-Rokotov , D.,Staresinic , M.,Anic , T.,Mikus , D., 2001.and propranolol, but not ranitidine,J. Physiol. 4257 00044 -4
[29] Santhrani , T.,Maheswari , E.,Saraswathy , G.R., 2013.Carbamazepine provoked hepatotoxicity: Attenuation by vitamin C. Oxidant, 2 37 -43
[30] Santos , N.A.,Medina , W.S.,Martins , N.M.,Rodrigues , M.A.,Curti , C.,Santos , A.C., 2008.Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs,Toxicol 08 1820 -1824
[31] Sasaki , E.,Iida , A.,Oda , S.,Tsuneyama , K.,Fukami , T.,Nakajima , M.,Yokoi , T., 2015.Pathogenetic analyses of carbamazepine-induced liver injury in F344 rats focused on immune-and inflammationrelated factors,Exp. Toxicol 09 27 -38
[32] Shi , L.,Dang , X.L.,Liu , X.Y.,Wei , H.M.,Yang , M.,Zhang, 2014.Effect of Sophora flavescens on the pharmacokinetics of carbamazepine in rats,Arch. Pharm. Res. 37 1617 -1623
[33] Tarantino , G.,DiMinno,M.N. and Capone,D., 2009.Drug-induced liver injury: Is it somehow foreseeable?,World J. Gastroenterol. 15 2817 -2833
[34] Thapa , B.,Walia , A., 2007.Liver function tests and their interpretation,Indian J. Pediat. 74 663 -671
[35] Tursi , T., 2010.Use of ss-blocker therapy to prevent primary bleeding of esophageal varices,J. Am. Acad. Nurse Pract 00567 7599 -647
[36] Zheng , E.,Navarro , V., 2016.Drug-induced liver injury in the United States: A review of multiingredient supplements,Clin. Liver Dis 7 60 -63